BioSupply Trends Quarterly logo
Subscribe
Winter 2016 - Plasma
  Download Issue
Share

Up Front

Publisher's Corner
Leveraging the Benefits of Biologic Medicines
By Patrick M. Schmidt

Features

Myths and Facts: Alzheimer’s Disease

The Nurse Practitioner Will See You Now

How Crowdsourcing Is Changing Medicine

Immunodeficiency in Older Adults

Superbugs: Challenging Our Notions of Medical Supremacy

BioSupply Trends Quarterly Winter 2016 Biosimilars

Future Biosimilars Pros and Cons

BioTrends Watch

Washington Report
Federal Funds for Coordinated Care Go Unclaimed
Healthcare.gov Now Features Window Shopping Upgrades
Federal Government Releases Claims and Payment Data
Senate's FDA Funding Bill Falls Short of What Was Requested
Rare Clinical Trial Compensation Legislation Is Signed Into Law
Reimbursement FAQs
The Shift to Payment for Value Continues: OPPS 2016 Final Rule
Industry News
Serious Flu Risk Could Be Identified with Genetic Test
New Study Shows No Link Between Vaccines and Autism
Studies Suggest Flu Vaccine Is Long-Lasting and Reduces Hospitalizations
FDA Approves NUWIQ to Treat Hemophilia A
FDA Approves Belbuca Buccal Film for Chronic Pain
CMS Announces Biosimilars Reimbursement Rule
FDA Approves First Combination Immunotherapy for Melanoma
Incorrect Statistic Reported in Fall Issue of BioSupply Trends Quarterly Magazine
FDA Approves First-in-Class Treatment of Melanoma
First Factor X Deficiency Bleeding Disorder Therapy Is Approved

BioFocus

Industry Insight
BabyBIG: Definitive Early Immunotherapy for Infant Botulism
By Keith Berman, MPH, MBA
Patient Profile
Beating the Odds with CVID
By Trudie Mitschang
Physician Profile
Primary Immunodeficiency Disease: A Physician's Perspective
By Trudie Mitschang

BioSources

BioResearch
IVIG Used as First-Line Monotherapy Attenuates Statin-Triggered Autoimmune Myopathy
Short Course of IVIG May Slow Brain Atrophy and Conversion to Dementia in Persons with MCI Stage Alzheimer's Disease